Study of Body Mass Index and Premenopausal or Postmenopausal Breast Cancer

被引:1
|
作者
Garg, Alka [1 ]
Garg, Navneet [2 ]
Kumar, Lalit [3 ]
机构
[1] Rama Med Coll, Dept Gynaecol & Obstet, Hapur, Uttar Pradesh, India
[2] Rama Med Coll, Dept Gen Surg, Hapur, Uttar Pradesh, India
[3] Shri Guru Ram Rai Inst Med & Hlth Sci, Dept Forens Med & Toxicol, Dehra Dun 248001, Uttarakhand, India
关键词
Body mass index; Breast cancer; Obesity; Post menopause; Pre menopause; Risk; Women;
D O I
10.17354/ijss/2015/168
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Introduction: Obesity has increased its role in prevalence of many diseases since the early 1980s, as acknowledged in many studies and strongly suggests that obesity represented by body mass index (BMI) increases the relative risk of premenopausal or postmenopausal breast cancer. Materials and Methods: A retrograde study of total 200 case patients who were newly diagnosed with breast cancer and 200 controls of women ages 35-64 years were taken for the study. The point of this study was Rama Medical College, Hapur, Uttar Pradesh. All subjects were interviewed using a structured questionnaire prepared on demographics, reproductive history, medical history, including weight and height, family history of breast cancer and other life-style factors. BMI was calculated at the age of 18 and recent at the time of diagnosis of breast cancer. Results: Author observed in premenopausal breast cancer women having BMI at 18 years age <20 (reference value) were 50% and in control group 46%. Author calculated the ORBMI (>= 25kg/m2) (versus) (<20 kg/m2) = 0.67. Apart of BMI, maximum cases of weight change since 18 years weight was 5.1-15.0 kg group in premenopausal women 39% and in the control group 38%. In postmenopausal breast cancer women, the odds ratio (OR) found the borderline results. Apart of BMI, maximum cases of weight change since 18 years weight was 5.1-15.0 kg group in postmenopausal women 35% and in control group 31% and OR showed ORweight change 5.1-15 kg versus <5 kg = 1.19. Overall ORBMI >= 25 kg/m2 (versus <20 kg/m2) = 0.67. Conclusion: This study found an inverse association between increasing BMI at age 18 years and risk of breast cancer in women ages 35-64 years especially in premenopausal women. In postmenopausal women, BMI at the age of 18 and recent BMI did not have any significant effect on breast cancer incidence, but weight change from 18 years age to recent had the direct association with breast cancer.
引用
收藏
页码:116 / 119
页数:4
相关论文
共 50 条
  • [21] Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study
    Feigelson, HS
    Jonas, CR
    Teras, LR
    Thun, MJ
    Calle, EE
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (02) : 220 - 224
  • [22] Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study
    Montazeri, Ali
    Sadighi, Jila
    Farzadi, Faranak
    Maftoon, Farzaneh
    Vahdaninia, Mariam
    Ansari, Mariam
    Sajadian, Akram
    Ebrahimi, Mandana
    Haghighat, Shahpar
    Harirchi, Iraj
    BMC CANCER, 2008, 8 (1)
  • [23] Waist circumference, body mass index, and postmenopausal breast cancer incidence in the Cancer Prevention Study-II Nutrition Cohort
    Gaudet, Mia M.
    Carter, Brian D.
    Patel, Alpa V.
    Teras, Lauren R.
    Jacobs, Eric J.
    Gapstur, Susan M.
    CANCER CAUSES & CONTROL, 2014, 25 (06) : 737 - 745
  • [24] The correlation between body mass index (BMI) and breast cancer in both premenopausal and menopausal women in Okinawa
    Tamaki, K.
    Tamaki, N.
    Kamada, Y.
    Uehara, K.
    Sasano, H.
    Ishida, T.
    Miyashita, M.
    Ohuchi, N.
    CANCER RESEARCH, 2013, 73
  • [25] Waist circumference, body mass index, and postmenopausal breast cancer incidence in the Cancer Prevention Study-II Nutrition Cohort
    Mia M. Gaudet
    Brian D. Carter
    Alpa V. Patel
    Lauren R. Teras
    Eric J. Jacobs
    Susan M. Gapstur
    Cancer Causes & Control, 2014, 25 : 737 - 745
  • [26] Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer according to body mass index
    Gevorgyan, A.
    Ganzinelli, M.
    Martinetti, A.
    Lo Vullo, S.
    Mariani, L.
    Festinese, F.
    Sottotetti, E.
    Ferrari, B.
    Galli, G.
    de Braud, F.
    Di Cosimo, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 12 - 13
  • [27] Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women
    Petrelli, JM
    Calle, EE
    Rodriguez, C
    Thun, MJ
    CANCER CAUSES & CONTROL, 2002, 13 (04) : 325 - 332
  • [28] Breast cancer size in postmenopausal women is correlated with body mass index and androgen serum levels
    Asseryanis, E
    Ruecklinger, E
    Hellan, M
    Kubista, E
    Singer, CF
    GYNECOLOGICAL ENDOCRINOLOGY, 2004, 18 (01) : 29 - 36
  • [29] The body mass index (BMI) and the effectiveness of the fulvestrant as treatment postmenopausal metastatic breast cancer patients
    Jagiello-Gruszfeld, A.
    Lemanska, I.
    Gorniak, A.
    Kunkiel, M.
    Glinka, E.
    Majstrak-Hulewska, A.
    Konieczna, A.
    Niwinska, A.
    Nowecki, Z.
    BREAST, 2019, 44 : S66 - S66
  • [30] Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women
    Jennifer M. Petrelli
    Eugenia E. Calle
    Carmen Rodriguez
    Michael J. Thun
    Cancer Causes & Control, 2002, 13 : 325 - 332